Golden Throat Holdings Group Company Limited (HKG:6896)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals	943.26M	1.19B	961.38M	992.01M	820.54M
Pharmaceuticals Growth	-20.40%	23.26%	-3.09%	20.90%	26.83%
Total	943.26M	1.19B	961.38M	992.01M	820.54M
Total Growth	-20.40%	23.26%	-3.09%	20.90%	26.83%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Chinese Mainland	933.67M	1.18B	951.64M	984.38M	817.13M
Chinese Mainland Growth	-20.75%	23.80%	-3.33%	20.47%	27.31%
Other Countries/Regions	9.59M	6.90M	9.74M	7.63M	3.41M
Other Countries/Regions Growth	39.04%	-29.18%	27.61%	123.59%	-33.03%
Total	943.26M	1.19B	961.38M	992.01M	820.54M
Total Growth	-20.40%	23.26%	-3.09%	20.90%	26.83%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 8, 2026

Data Sources Report a data error